Pharmadons (0885.520.423): financials and annual accounts

Pharmadons

Ixelles ·KBO/BCE: BE 0885.520.423

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Balance sheet: assets
`20/58`	608,875	534,160	469,098	424,624	334,988	277,387	207,163	200,868	198,566	213,842	300,276	346,966	368,149	411,653	495,983	597,270	631,228	592,729	746,788
`21/28`	14,621	4,955	5,573	8,319	4,449	6,440	5,633	5,579	10,976	16,484	71,694	122,610	160,212	219,429	269,547	328,937	382,568	399,450	449,581
`21`	-	-	-	-	-	-	-	-	-	0	29,000	58,000	87,000	116,000	145,000	174,000	203,000	232,000	261,000
`22/27`	10,121	4,955	5,573	8,319	4,449	6,440	5,633	5,579	10,976	16,484	42,694	64,610	73,212	103,429	124,547	154,937	179,568	167,450	188,581
`23`	4,937	0	1,179	2,257	921	1,657	2,423	3,189	5,066	10,436	13,406	10,406	7,676	9,092	7,904	12,001	11,521	1,721	1,498
`24`	5,184	4,955	4,393	6,062	3,528	4,782	3,210	2,390	5,909	6,048	29,288	54,204	65,536	94,337	116,643	142,936	168,047	165,729	187,083
`28`	4,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`29/58`	594,254	529,205	463,526	416,305	330,538	270,948	201,530	195,289	187,590	197,358	228,582	224,356	207,937	192,224	226,436	268,333	248,660	193,279	297,207
`3`	81,593	101,210	99,537	98,111	95,388	108,995	104,849	104,441	108,386	111,758	129,162	136,190	130,576	114,935	122,302	138,394	106,475	140,157	146,140
`30/36`	81,593	101,210	99,537	98,111	95,388	108,995	104,849	104,441	108,386	111,758	129,162	136,190	130,576	114,935	122,302	138,394	106,475	140,157	146,140
`40/41`	455,489	365,228	37,851	34,982	49,561	40,884	40,707	48,692	33,274	37,832	60,137	51,202	40,628	45,005	59,349	74,226	86,061	7,008	94,188
`40`	50,825	45,795	34,833	34,982	46,061	38,884	28,769	35,788	29,116	33,813	56,670	51,202	39,690	44,393	59,349	72,914	65,635	7,008	39,111
`41`	404,664	319,433	3,018	-	3,500	2,000	11,938	12,904	4,157	4,019	3,467	-	938	612	-	1,312	20,426	-	55,077
`54/58`	49,883	61,130	325,729	282,880	185,213	121,012	55,101	41,364	45,931	47,768	39,283	36,964	36,733	32,284	44,785	55,713	56,124	46,114	56,879
`490/1`	7,289	1,638	408	331	376	57	873	792	-	-	-	-	-	-	-	-	-	-	-
Balance sheet: equity and liabilities
`10/49`	608,875	534,160	469,098	424,624	334,988	277,387	207,163	200,868	198,566	213,842	300,276	346,966	368,149	411,653	495,983	597,270	631,228	592,729	746,788
`10/15`	98,180	407,926	415,121	345,854	276,538	201,574	116,092	86,261	56,306	29,792	16,123	-12,785	3,701	-8,595	-13,109	-53,032	-94,695	-59,588	-3,511
`10/11`	18,600	18,600	18,600	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200
`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`101`	-	-	-	-	-	-	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400
`13`	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-
`130/1`	-	0	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-
`130`	-	-	-	-	-	-	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-
`1311`	-	0	1,860	1,860	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-
`133`	1,860	1,860	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`14`	77,720	387,466	394,661	337,794	268,478	193,514	108,032	78,201	48,246	21,732	9,923	-18,985	-2,499	-14,795	-19,309	-59,232	-100,895	-65,788	-9,711
`17/49`	510,695	126,234	53,977	78,770	58,449	75,813	91,072	114,607	142,260	184,050	284,153	359,751	364,448	420,248	509,092	650,302	725,923	652,317	750,299
`17`	13,105	5,822	-	-	-	-	-	-	-	-	1,607	10,689	21,103	35,029	50,720	70,516	89,344	83,586	-
`170/4`	0	5,822	-	-	-	-	-	-	-	-	1,607	10,689	21,103	35,029	50,720	70,516	89,344	83,586	-
`178/9`	13,105	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`42/48`	497,590	120,412	53,977	78,770	58,449	75,813	91,072	114,607	142,260	184,050	282,535	349,062	343,345	385,219	458,372	579,786	636,579	568,731	750,299
`42`	18,329	14,178	-	-	-	-	-	-	-	5,174	9,082	17,359	13,926	15,691	19,797	18,828	17,898	10,545	-
`43`	28,379	0	4,099	4,264	7,926	4,356	4,351	-	3,339	-	-	-	-	-	-	-	-	-	-
`430/8`	28,379	0	4,099	4,264	7,926	4,356	4,351	-	3,339	-	-	-	-	-	-	-	-	-	-
`44`	135,996	85,139	20,969	38,666	23,165	21,968	19,932	25,853	38,211	55,759	55,343	52,036	63,513	53,952	63,678	86,178	82,521	15,283	55,046
`440/4`	135,996	85,139	20,969	38,666	23,165	21,968	19,932	25,853	38,211	55,759	55,343	52,036	63,513	53,952	63,678	86,178	82,521	15,283	55,046
`45`	14,886	17,441	28,908	28,434	23,790	30,707	16,373	16,112	17,184	3,662	1,069	24,967	11,736	4,555	6,349	2,711	26,698	10,097	61,333
`450/3`	0	6,930	11,753	12,246	9,095	7,665	3,096	6,115	5,061	3,662	1,069	3,758	-	-	987	-	19,645	2,239	54,097
`454/9`	14,886	10,511	17,155	16,188	14,695	23,043	13,277	9,997	12,123	-	-	21,209	11,736	4,555	5,362	2,711	7,053	7,858	7,236
`47/48`	300,000	3,654	-	7,405	3,568	18,782	50,415	72,642	83,526	119,455	217,041	254,700	254,170	311,021	368,548	472,069	509,462	532,806	633,920
`492/3`	-	-	-	-	-	-	-	-	-	-	11	-	-	-	-	-	-	-	-
Income statement
`76A`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	500	-	-	-	-
`9900`	110,101	149,579	207,133	213,857	211,276	224,906	173,499	181,940	160,384	189,180	183,571	187,720	194,998	183,107	186,211	208,173	140,302	141,424	183,679
`62`	118,426	150,691	125,399	123,488	113,222	112,442	129,297	134,776	112,611	108,282	94,839	141,970	113,317	106,801	79,995	99,670	104,369	140,109	139,498
`630`	2,068	1,856	2,746	2,130	1,990	2,074	2,834	5,397	5,509	57,193	56,886	56,501	59,777	60,886	60,408	59,825	60,182	52,518	52,829
`640/8`	416	392	-	0	1	-	-	-	2,663	3,998	2,575	3,718	1,253	3,616	1,124	1,292	4,313	809	821
`9901`	-10,809	-3,359	78,988	88,239	96,063	110,390	41,368	41,767	39,601	19,707	29,271	-14,469	20,651	11,804	44,684	47,386	-28,562	-52,012	-9,469
`75/76B`	67	3	-	-	1	0	36	-	302	4	-	2	6	15	-	338	140	149	-
`75`	67	3	-	-	1	0	36	-	302	4	-	2	6	15	-	338	140	149	-
`65/66B`	4,439	3,839	2,192	1,633	2,101	2,850	3,647	3,662	2,547	1,059	363	2,019	3,354	4,415	5,261	6,061	6,660	4,214	242
`65`	4,439	3,839	2,192	1,633	2,101	2,850	3,647	3,662	2,547	1,059	363	2,019	3,354	4,415	5,261	6,061	6,660	4,214	242
`9903`	-15,180	-7,195	76,797	86,605	93,962	107,541	37,757	38,105	37,356	18,652	28,908	-16,486	17,303	7,404	39,923	41,663	-35,082	-56,077	-9,711
`67/77`	-5,434	0	19,930	17,289	18,998	22,058	7,926	8,150	10,843	4,983	-	-	5,007	2,890	-	-	-	-	-
`9904`	-9,746	-7,195	56,867	69,316	74,964	85,483	29,830	29,956	26,513	13,669	28,908	-16,486	12,296	4,514	39,923	41,663	-35,082	-56,077	-9,711
`9905`	-9,746	-7,195	56,867	69,316	74,964	85,483	29,830	29,956	26,513	13,669	28,908	-16,486	12,296	4,514	39,923	41,663	-35,082	-56,077	-9,711
Appropriation of the result
`9906`	377,720	387,466	394,661	337,794	268,478	193,514	108,032	78,201	48,246	23,592	9,923	-18,985	-2,499	-14,795	-19,309	-59,232	-100,895	-65,788	-9,711
`14P`	387,466	394,661	337,794	268,478	193,514	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`691/2`	-	-	-	-	-	-	-	-	-	1,860	-	-	-	-	-	-	-	-	-
`6920`	-	-	-	-	-	-	-	-	-	1,860	-	-	-	-	-	-	-	-	-
`694/7`	300,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`694`	300,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Social balance sheet
`9087`	1.3	2	2.3	2	2	2	2	2.8	3.4	2.3	2	2.2	2.6	2.4	2.3	2.6	2.3	2.2	2.3
Hours worked`1013`	2,148	2,783	3,373	3,441	3,355	3,457	3,507	4,634	4,257	3,990	3,357	3,439	2,722	4,010	3,020	4,114	3,366	3,702	4,243
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	14-08-2026	2026-00412462	PDF
31-12-2024	full format	11-08-2025	2025-00368964	PDF
31-12-2023	micro format	25-06-2024	2024-00166101	PDF
31-12-2022	micro format	28-08-2023	2023-00431337	PDF
31-12-2021	micro format	23-06-2022	2022-20097547	PDF
31-12-2020	micro format	05-07-2021	2021-31800013	PDF
31-12-2019	micro format	06-07-2020	2020-26800375	PDF
31-12-2018	micro format	27-06-2019	2019-25300278	PDF
31-12-2017	micro format	27-06-2018	2018-25900093	PDF
31-12-2016	full format	26-06-2017	2017-22300595	PDF
31-12-2015	full format	13-06-2016	2016-18000371	PDF
31-12-2014	full format	24-06-2015	2015-21200154	PDF
31-12-2013	full format	13-06-2014	2014-17900069	PDF
31-12-2012	full format	14-06-2013	2013-17900285	PDF
31-12-2011	full format	22-06-2012	2012-20400099	PDF
31-12-2010	full format	23-06-2011	2011-20500435	PDF
31-12-2009	full format	24-06-2010	2010-21400341	PDF
31-12-2008	full format	29-06-2009	2009-33100142	PDF
31-12-2007	full format	26-06-2008	2008-30000126	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
-8,741	-1,503	81,734	90,369	98,053	112,464	44,201	47,164	45,110	76,900	86,157	42,032	80,428	72,690	105,092	107,211	31,620	506	43,360
-7,678	-5,339	59,613	71,447	76,954	87,556	32,664	35,352	32,022	70,862	85,794	40,015	72,073	65,400	100,331	101,488	25,100	-3,559	43,118
7,235	1,238	0	6,000	0	2,880	2,888	0	0	1,984	5,970	18,900	560	10,768	3,750	6,194	43,300	2,387	501,560
-11,247	-264,599	42,849	97,668	64,201	65,911	13,737	-4,567	-1,837	8,485	2,319	231	4,449	-12,501	-10,928	-411	10,010	-10,765	-
96,664	408,794	409,549	337,535	272,089	195,135	110,458	80,682	45,330	13,308	-53,953	-124,706	-135,408	-192,995	-231,936	-311,453	-387,919	-375,452	-453,092
16.1%	76.4%	88.5%	81.4%	82.6%	72.7%	56.0%	42.9%	28.4%	13.9%	5.4%	-3.7%	1.0%	-2.1%	-2.6%	-8.9%	-15.0%	-10.1%	-0.5%
1.19	4.39	8.59	5.29	5.66	3.57	2.21	1.70	1.32	1.07	0.81	0.64	0.61	0.50	0.49	0.46	0.39	0.34	0.40
1.03	3.55	6.74	4.04	4.02	2.14	1.06	0.79	0.56	0.47	0.35	0.25	0.23	0.20	0.23	0.22	0.22	0.09	0.20
5.20	0.31	0.13	0.23	0.21	0.38	0.78	1.33	2.53	6.18	17.62	-	98.47	-	-	-	-	-	-
-9.9%	-1.8%	13.7%	20.0%	27.1%	42.4%	25.7%	34.7%	47.1%	45.9%	179.3%	-	332.2%	-	-	-	-	-	-
-1.6%	-1.3%	12.1%	16.3%	22.4%	30.8%	14.4%	14.9%	13.4%	6.4%	9.6%	-4.8%	3.3%	1.1%	8.0%	7.0%	-5.6%	-9.5%	-1.3%
-1.97	-0.39	37.30	55.33	46.66	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	2	2	4	3	3
full-time	0	0	1	1	1
part-time	2	2	3	2	2
in full-time equivalents	1.3	1.3	2.6	2	2
	1.3	2	2.2	2	2
On a permanent contract	2	2	4	3	3
Joined	-	0	1	-	-
Left	-	2	0	-	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€7,235	€1,238	-	€6,000	-
Financial fixed assets	€0	-	-	-	-
	€2,068	€1,856	€2,746	€2,130	€1,990

Pharmadons

Annual accounts 2025

Balance sheet

in euro

in euro

Position in the sector

16.1%

1.19

-1.6%

Staff

€91,097

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on Pharmadons

Next steps

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency16.1%

Current ratio1.19

Return on assets-1.6%

Staff

Staff cost per FTE€91,097

Joined and left

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on Pharmadons

Next steps

in euro

in euro

16.1%

1.19

-1.6%

€91,097